Biotech

All Articles

Fierce Biotech's Gabrielle Masson offers Brutal 15 at NYSE

.Intense Biotech Associate Publisher Gabrielle Masson provided the 2024 lesson of Fierce 15 winners ...

Daiichi spends Merck $170M to develop lung cancer T-cell engager treaty

.Merck &amp Co. has rapidly redeemed several of the expenses of its Spear Rehabs acquistion, pulling...

BioMarin stops preclinical genetics treatment for heart condition

.After BioMarin carried out a springtime clean of its own pipe in April, the business has made a dec...

Eisai plants molecular glue SEED with $1.5 B biobucks deal

.Big Pharmas stay stuck to the suggestion of molecular glue degraders. The most up to date firm to o...

Life science credit rating firm introduces along with $600M

.A brand-new global life science credit score firm, nicknamed Symbiotic Financing, has reared greate...

BMS ditches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another big bet coming from the Caforio era, ending an o...

Nuvation halts BET prevention after taking into consideration phase 1 data

.After having a look at phase 1 data, Nuvation Biography has decided to halt work with its one-time ...

' Professional intuition' led FDA consultants to support Zevra's uncommon illness med

.Zevra Therapeutics' rare disease medication appears to become on the path to approval this loss aft...

Pfizer takes $230M struck after axing fell short DMD gene treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has gone a $230 mil...

AC Immune observes 'spots' possible in Alzheimer's medication data

.After greater than two decades of work with neurodegenerative conditions, Swiss biotech hvac Immune...